New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
JW Pharmaceutical Corporation
001060.KS
Shape
US Flag

KSC

525B

Drug Manufacturers - Specialty & Generic

Next Earning date - 30 Jul 2025

525B

Drug Manufacturers - Specialty & Generic

Next Earning date - 30 Jul 2025

23050.00KRW

Shape200.00 ( 0.88%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-4%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

34%

Quote Panel

Shape
Updated July 15, 2025
1W 0.44 % 1M 3.36 % 3M 6.96 % 1Y -31.01 %

Key Metrics

Shape
  • Market Cap

    524.71B


  • Shares Outstanding

    22.76M


  • Share in Float

    12.71M


  • Dividende

    450


  • Earning Date

    30 Jul 2025


  • Price Target

    23050


  • Average Volume

    52849


  • Beta

    1.035


  • Range

    19600-34950


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.jw-pharma.co.kr


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

001060.KS

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$882B

Shape376%

2026-Revenue

$3.78K

Shape398%

2026-EPS

$85B

Shape1%

2026-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+302%

558.33
vs -276.66

Q1.23

arrow
arrow

+57%

665.07
vs 424.91

Q2.23

arrow
arrow

+1145%

542
vs 43.55

Q3.23

arrow
arrow

N/A

-742.00
vs 367.58

Q4.23

arrow
arrow

+95%

1.1K
vs 558.33

Q1.24

arrow
arrow

+23%

816
vs 665.07

Q2.24

arrow
arrow

-36%

346
vs 542

Q3.24

arrow
arrow

+209%

807
vs -742.00

Q4.24

arrow
arrow

-35%

712
vs 1.1K

Q1.25

arrow
arrow

-12%

714
vs 816

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

+11%

173.4B  vs 156.3B

Q2.23

arrow
arrow

+13%

185.9B  vs 165B

Q3.23

arrow
arrow

+8%

184.2B  vs 169.8B

Q4.23

arrow
arrow

+6%

205B  vs 193.2B

Q1.24

arrow
arrow

+4%

180.6B  vs 173.4B

Q2.24

arrow
arrow

-7%

172.3B  vs 185.9B

Q3.24

arrow
arrow

-3%

178.7B  vs 184.2B

Q4.24

arrow
arrow

-8%

187.9B  vs 205B

Q1.25

arrow
arrow

+3%

185.2B  vs 180.6B

Q2.25

arrow
arrow

+8%

186.8B  vs 172.3B

Return on EquityShape

status-upQoQ

Q2.23

arrow
arrow

+5%

0.05
vs 0.06

Q3.23

arrow
arrow

-7%

-0.07
vs 0.05

Q4.23

arrow
arrow

+9%

0.09
vs -0.07

Q1.24

arrow
arrow

+7%

0.07
vs 0.09

Q2.24

arrow
arrow

+3%

0.03
vs 0.07

Q3.24

arrow
arrow

+6%

0.06
vs 0.03

Q4.24

arrow
arrow

+5%

0.05
vs 0.06

Q1.25

arrow
arrow

+5%

0.05
vs 0.05

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News